AngioDynamics, Inc. (ANGO) Net margin 2017–2026
AngioDynamics, Inc. (ANGO) net profit margin by fiscal year — reported net income divided by reported revenue.
-11.5%FY2026 · since FY2017: 1.9% → -11.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -11.5% | +0.1 pp |
| FY2025 | -11.6% | +49.0 pp |
| FY2024 | -60.7% | -45.2 pp |
| FY2023 | -15.5% | -7.1 pp |
| FY2022 | -8.4% | +2.4 pp |
| FY2021 | -10.8% | +52.3 pp |
| FY2020 | -63.1% | -85.8 pp |
| FY2019 | 22.7% | +16.4 pp |
| FY2018 | 6.2% | +4.4 pp |
| FY2017 | 1.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More ANGO financial trends
ANGO RevenueANGO Net incomeANGO Gross profitANGO Gross marginANGO Operating incomeANGO Operating marginANGO Operating cash flowANGO Free cash flowANGO Capital expendituresANGO Return on equityANGO Stock buybacksANGO Dividends paidANGO Total assetsANGO Total liabilitiesANGO Shareholders’ equityANGO overview →